Skip to content

Checked

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

NCT06134232 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Phase 2
Interventional
Planned enrollment
400
Participants, all sites
U.S. sites
31
In 18 states

Study details

Conditions
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sponsor
Dendreon (Industry)
Ages
18 years and older
Sex
Male only
Healthy volunteers
Not accepted
Start
10/02/2023
Primary completion (expected)
12/31/2031
Last updated by sponsor
08/27/2025

Full eligibility rules, contacts and site names: NCT06134232 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Arizona: Tuscon
  • California: Duarte, Fresno, San Diego
  • Colorado: Lakewood
  • Florida: Daytona Beach, Largo, Ocala, Riverview
  • Illinois: Chicago Ridge, Glenview, New Lenox
  • Indiana: Carmel, Jeffersonville, Merrillville
  • Maryland: Towson
  • Michigan: Troy
  • Missouri: St Louis
  • New York: North Hills, Syracuse
  • North Carolina: Raleigh
  • Ohio: Cincinnati, Gahanna
  • Oregon: Springfield
  • Pennsylvania: Bala-Cynwyd, Lancaster
  • South Carolina: Charleston, Myrtle Beach
  • Tennessee: Nashville
  • Virginia: Virginia Beach
  • Washington: Spokane

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 08/27/2025